These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Predictive value of serum levels of basic fibroblast growth factor, vascular endothelial growth factor and matrix metalloproteinase-2 in advanced carcinomas of the head and neck]. Dietz A, Rudat V, Vanselow B, Conradt C, Möhler T. HNO; 1999 Aug 15; 47(8):695-701. PubMed ID: 10506495 [Abstract] [Full Text] [Related]
28. Comparison of serum vascular endothelial growth levels between patients with and without ovarian malignancies. Dehaven K, Taylor DD, Gercel-Taylor C. Int J Gynecol Cancer; 2002 Aug 15; 12(6):715-9. PubMed ID: 12445248 [Abstract] [Full Text] [Related]
29. Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis. Karayiannakis AJ, Bolanaki H, Syrigos KN, Asimakopoulos B, Polychronidis A, Anagnostoulis S, Simopoulos C. Cancer Lett; 2003 May 08; 194(1):119-24. PubMed ID: 12706865 [Abstract] [Full Text] [Related]
30. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB. J Pathol; 2003 Jun 08; 200(2):183-94. PubMed ID: 12754739 [Abstract] [Full Text] [Related]
31. Vascular endothelial growth factor in ovarian cyst fluid. Boss EA, Massuger LF, Thomas CM, Geurts-Moespot A, Boonstra H, Sweep CG. Cancer; 2001 Jan 15; 91(2):371-7. PubMed ID: 11180084 [Abstract] [Full Text] [Related]
32. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Kim HK, Song KS, Park YS, Kang YH, Lee YJ, Lee KR, Kim HK, Ryu KW, Bae JM, Kim S. Eur J Cancer; 2003 Jan 15; 39(2):184-91. PubMed ID: 12509950 [Abstract] [Full Text] [Related]
33. [Correlations of serous levels of matrix metalloproteinases (MMP-2 and MMP-9) to invasion and metastasis of papillary thyroid carcinoma]. Yu HZ, Li ZP, Li SG, Wu CM. Ai Zheng; 2005 Jun 15; 24(6):740-2. PubMed ID: 15946492 [Abstract] [Full Text] [Related]
34. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Hyodo I, Doi T, Endo H, Hosokawa Y, Nishikawa Y, Tanimizu M, Jinno K, Kotani Y. Eur J Cancer; 1998 Dec 15; 34(13):2041-5. PubMed ID: 10070308 [Abstract] [Full Text] [Related]
35. Biomarkers of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer. Shaarawy M, El-Sharkawy SA. Acta Oncol; 2001 Dec 15; 40(4):513-8. PubMed ID: 11504312 [Abstract] [Full Text] [Related]
36. Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma. Šelemetjev S, Ðoric I, Paunovic I, Tatic S, Cvejic D. Am J Clin Pathol; 2016 Nov 01; 146(5):594-602. PubMed ID: 27806941 [Abstract] [Full Text] [Related]
37. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY. Br J Cancer; 2003 Jun 02; 88(11):1721-6. PubMed ID: 12771987 [Abstract] [Full Text] [Related]
39. Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuron-specific enolase or lactate dehydrogenase. Mall JW, Schwenk W, Philipp AW, Meyer-Kipker C, Mall W, Muller J, Pollmann C. Respirology; 2002 Jun 02; 7(2):99-102. PubMed ID: 11985730 [Abstract] [Full Text] [Related]
40. [Detection of serum levels of MMP-9 and VEGF in patients with bladder cancer]. Guan KP, Hou SK, Yan Z, Ye HY. Zhonghua Wai Ke Za Zhi; 2003 Jun 02; 41(6):430-2. PubMed ID: 12895351 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]